Cipla Limited has informed the Exchange regarding grant of stock options and the employee stock appreciation rights .
CIPLA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cipla's Board of Directors approved the grant of stock options and employee stock appreciation rights (ESARs) under two schemes. Under the Employee Stock Option Scheme 2013-A, 176,389 stock options were granted with vesting periods of 1-2 years at an exercise price of INR 2 per option. Under the ESAR 2021 scheme, 596,244 ESARs were granted with vesting periods of 1-3 years at an exercise price of INR 2 per share. All grants have an exercise period of 5 years from the vesting date. The Board also approved convening the 90th AGM on 25th June 2026, appointment of M/s Joshi Apte & Associates as Cost Auditors for FY 2026-27, and appointment of Mr Sushrut Kulkarni as President & Global Chief – Integrated Product Development effective 18th May 2026.
This is a routine employee compensation announcement. The stock option grants align employee interests with shareholders but result in modest dilution. The exercise price of INR 2 is significantly below market, which may impact future earnings per share upon exercise. No direct impact on near-term stock price expected.